Description

GenomeWeb webinar recorded on September 2023.

This webinar highlights the breakthrough use of Whole Genome Sequencing (WGS) combined with DNA Nanoball Sequencing for ultrasensitive Minimal Residual Disease (MRD) detection and monitoring in oncology.

The method’s high-throughput precision facilitates the identification and quantification of residual cancer cells post-treatment. WGS offers a detailed genomic profile, enhancing understanding of cancer evolution and resistance to treatment. This approach signifies a leap towards improved patient outcomes and personalized treatment strategies, marking a new phase in cancer care.

Talk

WGS for Ultrasensitive MRD Detection & Monitoring with DNA Nanoball Sequencing

Li Weng, PhD
SVP and Head of R&D
AccuraGen